99 related articles for article (PubMed ID: 20802023)
1. Complement factor H is elevated in bronchoalveolar lavage fluid and sputum from patients with lung cancer.
Pio R; Garcia J; Corrales L; Ajona D; Fleischhacker M; Pajares MJ; Cardenal F; Seijo L; Zulueta JJ; Nadal E; Witt C; Lozano MD; Schmidt B; Montuenga LM
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2665-72. PubMed ID: 20802023
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic value of postbronchoscopic sputum, bronchoscopic lavage, and transbronchial biopsy in peripheral lung cancer].
Yüksekol I; Balkan A; Ozkan M; Sevketbeyoğlu H; Bilgiç H; Ekiz K; Demirci N; Seber O
Tuberk Toraks; 2003; 51(3):258-64. PubMed ID: 15143403
[TBL] [Abstract][Full Text] [Related]
3. The role of bronchoalveolar lavage in providing access to the evaluation of immune mechanisms taking place in lung cancer.
Semenzato G
Bull Cancer; 1989; 76(8):787-95. PubMed ID: 2695177
[TBL] [Abstract][Full Text] [Related]
4. Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment.
Hsu HS; Chen TP; Wen CK; Hung CH; Chen CY; Chen JT; Wang YC
J Pathol; 2007 Dec; 213(4):412-9. PubMed ID: 17973238
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of a multiple biomarker assay in bronchoalveolar lavage (BAL) and serum for the diagnosis of small cell lung cancer.
Nikliński J; Chyczewska E; Furman M; Kowal E; Laudanski J; Chyczewski L
Neoplasma; 1993; 40(5):305-8. PubMed ID: 8272160
[TBL] [Abstract][Full Text] [Related]
6. [Morphological diagnosis of early cancer of the lung].
Ermolova TP; Lipova VA
Arkh Patol; 1988; 50(4):32-7. PubMed ID: 3408368
[TBL] [Abstract][Full Text] [Related]
7. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
Unsal E; Köksal D; Yurdakul AS; Atikcan S; Cinaz P
Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452
[TBL] [Abstract][Full Text] [Related]
8. [The diagnostic value of ribonuclease in bronchoalveolar lavage fluid to bronchogenic carcinoma].
Tan XJ
Zhonghua Jie He He Hu Xi Za Zhi; 1991 Feb; 14(1):25-6, 62. PubMed ID: 1652376
[TBL] [Abstract][Full Text] [Related]
9. [The clinical diagnosis value of fibro-optic bronchoscope examination combined with tumor marker determination to lung cancer].
Yang YJ; Cheng DY; Fang X; Li XX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 38(2):312-5. PubMed ID: 17441358
[TBL] [Abstract][Full Text] [Related]
10. The role of bronchoscopy in lung cancer.
Arroliga AC; Matthay RA
Clin Chest Med; 1993 Mar; 14(1):87-98. PubMed ID: 8462250
[TBL] [Abstract][Full Text] [Related]
11. Molecular diagnostic markers for lung cancer in sputum and plasma.
Wang YC; Hsu HS; Chen TP; Chen JT
Ann N Y Acad Sci; 2006 Sep; 1075():179-84. PubMed ID: 17108209
[TBL] [Abstract][Full Text] [Related]
12. The evaluation of soluble Fas and soluble Fas ligand levels of bronchoalveolar lavage fluid in lung cancer patients.
Erdoğan B; Uzaslan E; Budak F; Karadağ M; Ediger D; Oral B; Göral G; Ege E; Gözü O
Tuberk Toraks; 2005; 53(2):127-31. PubMed ID: 16100648
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of differential brushing of all branches of the bronchi in patients with sputum positive or suspected positive for lung cancer.
Sato M; Saito Y; Nagamoto N; Sagawa M; Kanma K; Takahashi S; Usuda K; Endo C; Fujimura S
Acta Cytol; 1993; 37(6):879-83. PubMed ID: 8249506
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of occult endobronchial malignancy in high risk patients with moderate sputum atypia.
Kennedy TC; Franklin WA; Prindiville SA; Cook R; Dempsey EC; Keith RL; Hirsch FR; Merrick TA; Shroyer KR; Petty TL; Byers T; Bunn PA; Miller YE
Lung Cancer; 2005 Aug; 49(2):187-91. PubMed ID: 16022912
[TBL] [Abstract][Full Text] [Related]
15. Bronchoalveolar lavage fluid of lung cancer patients: mapping the uncharted waters using proteomics technology.
Oumeraci T; Schmidt B; Wolf T; Zapatka M; Pich A; Brors B; Eils R; Fleischhacker M; Schlegelberger B; von Neuhoff N
Lung Cancer; 2011 Apr; 72(1):136-8. PubMed ID: 21334092
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of various cytological examinations by bronchoscopy in the diagnosis of peripheral lung cancer.
Kawaraya M; Gemba K; Ueoka H; Nishii K; Kiura K; Kodani T; Tabata M; Shibayama T; Kitajima T; Tanimoto M
Br J Cancer; 2003 Nov; 89(10):1885-8. PubMed ID: 14612897
[TBL] [Abstract][Full Text] [Related]
17. Sputum cytologic atypia predicts incident lung cancer: defining latency and histologic specificity.
Byers T; Wolf HJ; Franklin WA; Braudrick S; Merrick DT; Shroyer KR; Hirsch FR; Zeng C; Barón AE; Bunn PA; Miller YE; Kennedy TC
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):158-62. PubMed ID: 18199720
[TBL] [Abstract][Full Text] [Related]
18. Cancer-specific genomic instability in bronchial lavage: a molecular tool for lung cancer detection.
Liloglou T; Maloney P; Xinarianos G; Hulbert M; Walshaw MJ; Gosney JR; Turnbull L; Field JK
Cancer Res; 2001 Feb; 61(4):1624-8. PubMed ID: 11245475
[TBL] [Abstract][Full Text] [Related]
19. [Measurement of CA19-9 in bronchial lavage fluid from patients with lung cancer].
Asada K; Ogushi F; Tani K; Kawaji K; Nakahira S; Yasuoka S; Ogura T
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Sep; 30(9):1682-6. PubMed ID: 1447844
[TBL] [Abstract][Full Text] [Related]
20. Bronchoscopy and tuberculostearic acid assay in the diagnosis of sputum smear-negative pulmonary tuberculosis: a prospective study with the addition of transbronchial biopsy.
Chan CH; Chan RC; Arnold M; Cheung H; Cheung SW; Cheng AF
Q J Med; 1992 Jan; 82(297):15-23. PubMed ID: 1438665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
